Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.

Libura, Marta; Giebel, Sebastian; Piatkowska-Jakubas, Beata; Pawelczyk, Marta; Florek, Izabella; Matiakowska, Karolina; Jaźwiec, Bożena; Borg, Katarzyna; Solarska, Iwona; Zawada, Magdalena; Czekalska, Sylwia; Libura, Jolanta; Jakobczyk, Malgorzata; Karabin, Karolina; Paluszewska, Monika; Całbecka, Małgorzata; Gajkowska-Kulik, Justyna; Gadomska, Grazyna; Kielbinski, Marek; Ejduk, Anna; Kata, Dariusz; Grosicki, Sebastian; Wierzbowska, Agnieszka; Kyrcz-Krzemień, Sławomira; Warzocha, Krzysztof; Kuliczkowski, Kazimierz; Skotnicki, Aleksander B; Holowiecki, Jerzy; Jedrzejczak, Wiesław Wiktor; Haus, Olga

doi:10.1182/blood-2015-08-662130

Record: found
Abstract: not found
Article: not found

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.

Author(s): Marta Libura ¹ , Sebastian Giebel ² , Beata Piatkowska-Jakubas ³ , Marta Pawelczyk ¹ , Izabella Florek ³ , Karolina Matiakowska ⁴ , Bozena Jazwiec ⁵ , Katarzyna Borg ⁶ , Iwona Solarska ⁶ , Magdalena Zawada ³ , Sylwia Czekalska ³ , Jolanta Libura ¹ , Malgorzata Jakobczyk ³ , Karolina Karabin ¹ , Monika Paluszewska ¹ , Malgorzata Calbecka ⁷ , Justyna Gajkowska-Kulik ⁷ , Grazyna Gadomska ⁸ , Marek Kielbinski ⁵ , Anna Ejduk ⁶ , Dariusz Kata ⁹ , Sebastian Grosicki ¹⁰ , Agnieszka Wierzbowska ¹¹ , Slawomira Kyrcz-Krzemien ⁹ , Krzysztof Warzocha ⁶ , Kazimierz Kuliczkowski ⁵ , Aleksander Skotnicki ³ , Jerzy Holowiecki ² , Wieslaw Wiktor Jedrzejczak ¹ , Olga Haus ¹²

Publication date (Electronic): Jan 21 2016

Journal: Blood

Publisher: American Society of Hematology

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Blood

Title: Blood

Publisher: American Society of Hematology

ISSN (Electronic): 1528-0020

ISSN (Print): 0006-4971

Publication date (Electronic): Jan 21 2016

Volume: 127

Issue: 3

Affiliations

[1 ] Medical University of Warsaw, Warsaw, Poland.

[2 ] Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland.

[3 ] Faculty of Medicine, Jagiellonian University, Cracow, Poland.

[4 ] Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.

[5 ] Medical University of Wroclaw, Wroclaw, Poland.

[6 ] Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

[7 ] Nicolaus Copernicus Municipal Specialist Hospital, Torun, Poland.

[8 ] Dr Biziel University Hospital, Bydgoszcz, Poland.

[9 ] Medical University of Silesia, Katowice, Poland.

[10 ] Municipal Specialist Hospital in Chorzow, Chorzow, Poland; and.

[11 ] Medical University of Lodz, Lodz, Poland.

[12 ] Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland Medical University of Wroclaw, Wroclaw, Poland.

Article

Publisher Item ID: blood-2015-08-662130

DOI: 10.1182/blood-2015-08-662130

PubMed ID: 26567156

SO-VID: b4f30616-42a3-40d9-acc7-17b78a080655

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.

Read this article at

Related collections

Special issue: Socio-Urban Critiques and a New Normal

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 1,571

Cited by 15